Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives

<b>Background:</b> Multiple sclerosis (MS) constitutes a chronic progressive demyelinating disease which negatively affects the central nervous system. MS symptoms detrimentally affect the quality of life, as well as the life expectancy of MS patients. In this aspect, the present study a...

Full description

Bibliographic Details
Main Authors: Christina Tryfonos, Maria Mantzorou, Dimitris Fotiou, Michael Vrizas, Konstantinos Vadikolias, Eleni Pavlidou, Constantinos Giaginis
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Medicines
Subjects:
Online Access:https://www.mdpi.com/2305-6320/6/3/95
id doaj-47f212a4bbdc4b4b8a0f52e2129095d2
record_format Article
spelling doaj-47f212a4bbdc4b4b8a0f52e2129095d22020-11-25T01:21:51ZengMDPI AGMedicines2305-63202019-09-01639510.3390/medicines6030095medicines6030095Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future PerspectivesChristina Tryfonos0Maria Mantzorou1Dimitris Fotiou2Michael Vrizas3Konstantinos Vadikolias4Eleni Pavlidou5Constantinos Giaginis6Department of Food Science and Nutrition, University of the Aegean, Myrina, 81400 Lemnos, GreeceDepartment of Food Science and Nutrition, University of the Aegean, Myrina, 81400 Lemnos, GreeceDepartment of Neurology, School of Medicine, Aristotelian University of Thessaloniki, 54624 Thessaloniki, GreeceDepartment of Neurology, School of Medicine, Democritus University of Thrace, 68100 Alexandroupoli, GreeceDepartment of Neurology, School of Medicine, Democritus University of Thrace, 68100 Alexandroupoli, GreeceDepartment of Food Science and Nutrition, University of the Aegean, Myrina, 81400 Lemnos, GreeceDepartment of Food Science and Nutrition, University of the Aegean, Myrina, 81400 Lemnos, Greece<b>Background:</b> Multiple sclerosis (MS) constitutes a chronic progressive demyelinating disease which negatively affects the central nervous system. MS symptoms detrimentally affect the quality of life, as well as the life expectancy of MS patients. In this aspect, the present study aims to critically summarize and evaluate the currently available clinical studies focusing on the potential beneficial effects of dietary supplements on controlling MS symptomatology and relapse. <b>Methods:</b> PubMed database was comprehensively searched, using relative keywords to identify clinical trials that investigated the beneficial effects of dietary supplementation against MS symptomatology and progression. 40 clinical trials were found, which were divided into categories. <b>Results:</b> Nutritional status of MS patients, as well as supplementation have been suggested as potential factors affecting progression. Several substantial studies have documented a systematically high prevalence of vitamin A, B12 and D3 deficiency amongst MS patients. At present, clinical data have suggested that most of the dietary supplements under study may exert antioxidant and anti-inflammatory properties, improving depression symptomatology and quality of life overall. However, malnutrition risk in MS patients has not been adequately explored in order for more precise conclusions to be drawn. The supplements that may have a positive effect on MS are vitamins, fatty acids, antioxidants, phytochemicals and melatonin. <b>Conclusions:</b> Several dietary supplements may decrease inflammation and fatigue, also increasing also autoimmunity tolerance in MS patients, and thus improving quality of life and life expectancy. Currently, there is no effective clinical indication for applying dietary supplementation as complementary treatment against MS symptomatology.https://www.mdpi.com/2305-6320/6/3/95dietary supplementsmultiple sclerosisinflammationantioxidantclinical studies
collection DOAJ
language English
format Article
sources DOAJ
author Christina Tryfonos
Maria Mantzorou
Dimitris Fotiou
Michael Vrizas
Konstantinos Vadikolias
Eleni Pavlidou
Constantinos Giaginis
spellingShingle Christina Tryfonos
Maria Mantzorou
Dimitris Fotiou
Michael Vrizas
Konstantinos Vadikolias
Eleni Pavlidou
Constantinos Giaginis
Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
Medicines
dietary supplements
multiple sclerosis
inflammation
antioxidant
clinical studies
author_facet Christina Tryfonos
Maria Mantzorou
Dimitris Fotiou
Michael Vrizas
Konstantinos Vadikolias
Eleni Pavlidou
Constantinos Giaginis
author_sort Christina Tryfonos
title Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
title_short Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
title_full Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
title_fullStr Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
title_full_unstemmed Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
title_sort dietary supplements on controlling multiple sclerosis symptoms and relapses: current clinical evidence and future perspectives
publisher MDPI AG
series Medicines
issn 2305-6320
publishDate 2019-09-01
description <b>Background:</b> Multiple sclerosis (MS) constitutes a chronic progressive demyelinating disease which negatively affects the central nervous system. MS symptoms detrimentally affect the quality of life, as well as the life expectancy of MS patients. In this aspect, the present study aims to critically summarize and evaluate the currently available clinical studies focusing on the potential beneficial effects of dietary supplements on controlling MS symptomatology and relapse. <b>Methods:</b> PubMed database was comprehensively searched, using relative keywords to identify clinical trials that investigated the beneficial effects of dietary supplementation against MS symptomatology and progression. 40 clinical trials were found, which were divided into categories. <b>Results:</b> Nutritional status of MS patients, as well as supplementation have been suggested as potential factors affecting progression. Several substantial studies have documented a systematically high prevalence of vitamin A, B12 and D3 deficiency amongst MS patients. At present, clinical data have suggested that most of the dietary supplements under study may exert antioxidant and anti-inflammatory properties, improving depression symptomatology and quality of life overall. However, malnutrition risk in MS patients has not been adequately explored in order for more precise conclusions to be drawn. The supplements that may have a positive effect on MS are vitamins, fatty acids, antioxidants, phytochemicals and melatonin. <b>Conclusions:</b> Several dietary supplements may decrease inflammation and fatigue, also increasing also autoimmunity tolerance in MS patients, and thus improving quality of life and life expectancy. Currently, there is no effective clinical indication for applying dietary supplementation as complementary treatment against MS symptomatology.
topic dietary supplements
multiple sclerosis
inflammation
antioxidant
clinical studies
url https://www.mdpi.com/2305-6320/6/3/95
work_keys_str_mv AT christinatryfonos dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT mariamantzorou dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT dimitrisfotiou dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT michaelvrizas dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT konstantinosvadikolias dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT elenipavlidou dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
AT constantinosgiaginis dietarysupplementsoncontrollingmultiplesclerosissymptomsandrelapsescurrentclinicalevidenceandfutureperspectives
_version_ 1725128926258266112